Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study

BACKGROUND AND AIM: Mild cognitive impairment (MCI) is characterized by declined cognitive function greater than that expected for a person's age. The clinical significance of this condition is its possible progression to dementia. MLC601 is a natural neuroprotective medication that has shown p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakdaman, Hossein, Amini Harandi, Ali, Abbasi, Mehdi, Delavar Kasmaei, Hosein, Ashrafi, Farzad, Gharagozli, Koroush, Assarzadegan, Farhad, Behnam, Behdad, Arabahmadi, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471755/
https://www.ncbi.nlm.nih.gov/pubmed/28626468
http://dx.doi.org/10.1159/000458521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471755/
https://www.ncbi.nlm.nih.gov/pubmed/28626468
http://dx.doi.org/10.1159/000458521

Ejemplares similares